Evaluation of beta-alanine- and GABA-substituted peptides as inhibitors of disease-linked protein aggregation.
Madine
Jillian
J
School of Biological Sciences, University of Liverpool, Liverpool L69 7ZB (UK). j.madine@liv.ac.uk
Wang
Xiaoyan
X
Brown
David R
DR
Middleton
David A
DA
D008027:Light; D010316:Particle Size; D010446:Peptide Fragments / Q000737:chemistry* / Q000494:pharmacology*; D011485:Protein Binding / Q000187:drug effects; D017510:Protein Folding / Q000187:drug effects; D012542:Scattering, Radiation; D051844:alpha-Synuclein / Q000737:chemistry* / Q000378:metabolism*; D015091:beta-Alanine / Q000737:chemistry*; D005680:gamma-Aminobutyric Acid / Q000737:chemistry*
D010446:Peptide Fragments; D051844:alpha-Synuclein; D015091:beta-Alanine; D005680:gamma-Aminobutyric Acid